September, 21 2026 Monday 20:48 Hrs
Last update 11-9-2025
  • SENSEX :   74,858.99

  • Commodity broking firm in India564.03( 0.76%) 21-Sep-2026
Positive
Sensex 74858.99 564.03  (0.76) 21-Sep-2026
Previous Day Close 74294.96
Today's High/Low
High Low
  •  
  •  
74987.4 74454.18

Company News Details

Cohance Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543064
INE03QK01018
117.0972556
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
COHANCE
87.61
16759.68
EPS(TTM)
Face Value()
Div & Yield %
5
1
0
 

Cohance Lifesciences Ltd
Cohance Lifesciences' Telangana units gets Form FDA 483 with observations from US FDA
Sep 05,2026

In a regulatory filing made on Saturday (05 September 2026), the company informed that the US FDA had inspected the Cohance's formulation (FDF) plant located at Shamshabad, Telangana, from 27 August 2026 to 4 September 2026.

The inspection concluded with the issuance of a Form FDA 483 containing four observations.

'The company has initiated appropriate corrective and preventive actions (CAPA) and will submit its response within the stipulated timeline,' Cohance Lifesciences said in a statement.

Cohance Lifesciences, formerly Suven Pharmaceuticals, is an innovator-focused global CRDMO formed through the merger of Cohance Life Sciences into Suven Pharmaceuticals. It is a technology-driven, integrated CDMO platform offering development and manufacturing solutions across complex APIs, performance materials, agrochemicals, ADCs, oligonucleotides and advanced chemistries for global pharmaceutical and life sciences customers.

The company had reported a consolidated net loss of Rs 24.12 crore in the quarter ended June 2026 as against net profit of Rs 48.88 crore during the previous quarter ended June 2025. Sales declined 23.13% to Rs 422.26 crore in Q1 FY27 as compared with Q1 FY26.

The scrip shed 0.78% to end at Rs 456.55 on the BSE on Friday.

Top

Attention Investor:

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.